Replies to post #172833 on Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I suggest you to read the latest 10-Q to get a better understanding of the financial position. The burn rate was $1.7M last quarter. I don't expect it to increase dramatically this year since the four ongoing trials should be mostly paid for.

Cash on hand is $3.9M, Aspire's balance is $19M and the shelf registration has $45M. I think the company can survive easily until the top-line data from all four trials are released.

Since you think bankruptcy is imminent, I'm curious to see your math. TIA.